Business
Noul Publishes Its Fifth Sustainability Report, Outlining a Vision for Growth and a Decade of Breakthroughs
Noul Co., Ltd. (CEO: David Lim), a medical AI company specializing in blood and cancer diagnostics, announced the release of its 2024–2025 Sustainability Report. Noul has annually assessed its performance in economic, social, and environmental areas and transparently disclosed the results to stakeholders through sustainability reports. This is the company's fifth publication.
About this update from Noul Co Ltd.
[{"type":"list","items":[{"val":[{"type":"text","content":""The next decade will focus on securing strong growth momentum by strengthening product competitiveness and profitability"","length":132,"tagName":"p"}]},{"val":[{"type":"text","content":"First technology-special listed company to join the Corporate Value-Up Program… "We will grow by faithfully responding to stakeholder needs and expectations."","length":168,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":300,"olType":false},{"type":"text","content":"YONGIN, South Korea, June 30, 2025 /PRNewswire/ -- Noul Co., Ltd. (CEO: David Lim), a medical AI company specializing in blood and cancer diagnostics, announced the release of its 2024–2025 Sustainability Report. Noul has annually assessed its performance in economic, social, and environmental areas and transparently disclosed the results to stakeholders through sustainability reports. This is the company's fifth publication.","length":433,"tagName":"p"},{"type":"image","alt":"Noul Publishes Its Fifth Sustainability Report, Outlining a Vision for Growth and a Decade of Breakthroughs","displaySize":"","headline":null,"caption":"Noul Publishes Its Fifth Sustainability Report, Outlining a Vision for Growth and a Decade of Breakthroughs","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":225,"url":"https://media.zenfs.com/en/prnewswire.com/22da2cb94f85fd1d9f9892ad2bc8cdb1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/UuaoH2ZOfvWgN2LPGYZteA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM5NztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/22da2cb94f85fd1d9f9892ad2bc8cdb1","width":400,"height":225}},"href":"https://mma.prnewswire.com/media/2721637/Photo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"CEO David Lim stated, "The year 2024 marked the end of Noul's first decade focused on technology development, and the beginning of a new phase of scale-up aimed at delivering business performance and enhancing corporate value. Based on the sustainability capabilities and outcomes built over the years, we strengthened our organizational fundamentals to become a global healthcare company with both profitability and growth." He added, "In the coming decade, we will focus on strengthening product competitiveness and profitability, while continuing R&...